Onkologie. 2019:13(2):73-77 | DOI: 10.36290/xon.2019.014

Upgrade pharmacotherapy for cancer pain

Kateřina Jirsová
Integrované onkologické centrum, Nemocnice Na Pleši, s. r. o., Nová Ves pod Pleší

Pain is one of the most frequent and most serious symptoms of advanced malignancies. We know, that pain is reported by 60 % of patients undergoing oncology treatment, about 70 % with advanced cancer and up to 90 % terminally ill patients. Uncontrolled pain can have a negative impact on the whole comfort and daily activities of the patient and can lead to deterioration of quality of his/her life. Treatment of the pain is just one part of the complex therapy of the whole set of cancer symptoms. The main aim of the pain treatment is to reach optimal control of the pain, to keep the highest level of the patient's activity and to minimize the side effects of such treatment. The crucial position in the cancer pain management has pharmacotherapy which is based on the WHO three step algorithm. We have a lot of pharmacology treatment options available, such as nonopioid analgesics, weak, and strong opioid medication, in several application forms. It is useful to add coanalgesics such as antidepressants or anticonvulsants in some cases.

Keywords: cancer pain, multidisciplinary care, opioids

Published: April 5, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jirsová K. Upgrade pharmacotherapy for cancer pain. Onkologie. 2019;13(2):73-77. doi: 10.36290/xon.2019.014.
Download citation

References

  1. Portenoy RK. Treatment of cancer pain. Lancet 2011; 377: 2236-2247. Go to original source... Go to PubMed...
  2. Syrjala KL, Jensen MP, Mendoza ME, et al. Psychological and behavioral approaches to cancer pain management. J Clin Oncol 2014; 32: 1703-1711. Go to original source... Go to PubMed...
  3. Hakl M. Léčba bolesti (Současné přístupy k léčbě bolesti a bolestivých syndromů). Praha: Mladá fronta, 2013: 237 s.
  4. Caraceni A, Cherny N, Fainsinger R, et al. Pain Measurement Tools and Methods in Clinical Research in Palliative Care: Recommendations of an Expert Working Group of the European Association of Palliative Care. Journal of Pain and Symptom Management 2002; 23: 239-255. Go to original source... Go to PubMed...
  5. Jadad AR, Browman GP. The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation. Jama 1995; 274: 1870-1873. Go to original source...
  6. Vargas-Schaffer G. Is the WHO analgesic ladder still valid? Twenty-four years of experience. Can Fam Physician 2010; 56: 514-517, e202-515.
  7. Vardy J, Agar M. Nonopioid Drugs in the Treatment of Cancer Pain. Journal of Clinical Oncology 2014; 32: 1677-1690. Go to original source... Go to PubMed...
  8. Kozák J, Lejčko J, Vrba I a kol. Opioidy. Praha: Mladá fronta, 2018: 464 s.
  9. Farmakoterapie nádorové bolesti. Linkos [online] Dostupné z: https://www.linkos.cz/lekar - a-multidisciplinarni-tym/diagnostika-a-lecba/modra-kniha-cos/aktualni-vydani-modre - knihy/24-32-farmakoterapie-nadorove-bolesti/
  10. Himelstein AL, Foster JC, Khatcheressian JL, et al. Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial. JAMA. 2017; 317(1): 48-58. Go to original source... Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.